Biotech

Immunovaccine Announces Preclinical Collaboration for DepoVax(TM)-Based Malaria Vaccine

HALIFAX, NOVA SCOTIA: Initial Study Conducted With The University of Edinburgh to Examine Vaccine Candidate's Effects on Malaria Parasites Linked to Most Severe Form of the Disease ...

Aldeyra Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter Overallotment Option

LEXINGTON, MA: ...

Angle PLC: Holding(s) in Company

GUILDFORD, SURREY: ...

US FDA Grants Orphan Drug Designation for Retrotope''s RT001 in the Treatment of Friedreich''s Ataxia

LOS ALTOS, CA: First-in-Human Clinical Trial for RT001 Is Now Fully Enrolled ...

Theravance Biopharma Completes Enrollment in All Three Phase 3 Clinical Studies of Revefenacin (TD-4208) for Treatment of Chronic Obstructive Pulmonary Disease (COPD)

DUBLIN, IRELAND: Top-Line Data Readout From Two Efficacy Trials Expected Late-Q3/Early-Q4 2016; Twelve-Month Safety Trial Targeted for Completion in 2017 ...

Tiziana Partnership with Cardiff Researchers Wins Innovation in Healthcare Award

LONDON, UNITED KINGDOM: ...

Avid Bioservices to Exhibit at the 2016 BIO International Convention

TUSTIN, CA: Showcasing Expanded Contract Manufacturing Capabilities From Early Stage Development to Commercialization; Onsite Access to Leading Biopharmaceutical Manufacturing Experts ...

Atossa Genetics Announces $10 Million At-the-Market Common Stock Purchase Agreement With Aspire Capital Fund, LLC

SEATTLE, WA: ...

Bradmer Announces First Quarter 2016 Financial Results

TORONTO, ONTARIO: ...

Aldeyra Therapeutics, Inc. Proposes Public Offering of Common Stock

LEXINGTON, MA: ...